ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1769

TNF-Stimulated Production of IL-15 by Fibroblast-Like Synoviocytes Mediates Human Resident Memory T Cells Development in Synovial Organoid Model

Margaret Chang1, Maryrose Hahn2, Madison Mangin1, Brian Wauford1, Rachel Blaustein3, Lauren Henderson1, Kevin Wei4 and Peter Nigrovic1, 1Boston Children's Hospital, Boston, MA, 2Division of Immunology, Boston Children's Hospital, Boston, MA, 3Brigham and Women's Hospital, Boston, MA, 4Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2023

Keywords: Fibroblasts, Synovial, Inflammation, rheumatoid arthritis, T Cell, Tissue Engineering

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1734–1775) RA – Etiology and Pathogenesis Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) and juvenile idiopathic arthritis (JIA) are chronic autoimmune diseases that tend to flare repeatedly in the same joints, displaying joint-specific memory. We have identified CD8+ tissue resident memory T cells (TRM) in human arthritic joints and demonstrated in murine models that these long-lived TRM remain in synovium during remission and act as key mediators of arthritis flares. However, the factors that drive TRM formation in the synovium have not been characterized. IL-15 supports CD8 T cell activation and TRM development in other tissues. It is also elevated in synovial fluid and is expressed in the synovium in RA. Here, we explored the inflammatory drivers of IL-15 production by synovial stromal cells and investigated the role of IL-15 in synovial TRM development.

Methods: Fibroblast-like synoviocytes (FLS) isolated from human RA synovium and human umbilical vein endothelial cells (HUVEC) were grown in tissue culture and stimulated with TNF, IL-1beta, IL-6 or IFNgamma for 48 hours. Cells were collected, and IL-15 mRNA expression was assessed by quantitative PCR. To study human synovial TRM development, we developed a 3D synovial organoid that recapitulates the synovial stromal structure utilizing FLS and HUVEC encapsulated in Matrigel. CD8 memory T cells were isolated from peripheral blood of healthy donors and co-cultured with the synovial organoid for 2-3 weeks to generate TRM. TRM development was validated by cell surface markers, gene expression profile, free fatty acid uptake and migratory response to tissue egress signals. TNF was added to the culture media for 3-5 days to simulate inflammation, then removed for the duration in culture. IL-15 receptor alpha (IL-15Ra) or CD122 blocking antibodies were added to T cells 30 minutes prior to the formation of organoids, and they were replenished twice a week to inhibit IL-15 activity. After 3 weeks, cells were dissociated from the organoids and assayed for TRM surface phenotype by flow cytometry.

Results: TNF stimulation dramatically increased IL-15 gene expression in FLS by 30-fold, while it had a smaller effect on HUVEC (5-fold). IL-1beta also induced a 6-fold change in IL-15 expression in FLS, but IL-6 and IFNgamma did not. Culturing CD8 memory T cells in synovial organoids, particularly with TNF, supported the development of cells with TRM surface phenotype (CD45RO+CD62L-CCR7-HLADR-CD25-CD103+CD49a+) and TRM gene expression patterns. These TRM also had enhanced free fatty acid uptake, and they did not migrate across a transwell membrane in response to CCL21, further confirming TRM functionality. Inhibition of IL-15 activity with IL-15Ra or CD122 blocking antibodies reduced TRM development.

Conclusion: We developed a novel model for studying human synovial TRM by differentiating TRM within 3D synovial organoids composed of stromal cells from human RA synovium. We show that TNF preferentially induces FLS to produce IL-15 and demonstrate that IL-15 activity mediates TRM development in this synovial organoid system. As synovial TRM facilitate arthritis flares, effective methods to impede synovial TRM development may be valuable for durable disease control.


Disclosures: M. Chang: None; M. Hahn: None; M. Mangin: None; B. Wauford: None; R. Blaustein: None; L. Henderson: Adaptive Biotechnologies, 2, 5, Bristol-Myers Squibb(BMS), 5, Pfizer, 2, Sobi, 1, 2, 5; K. Wei: 10X Genomics, 5, capital one, 6, Gilead sciences, 5, horizon therapeutics, 6, Mestag, 2; P. Nigrovic: None.

To cite this abstract in AMA style:

Chang M, Hahn M, Mangin M, Wauford B, Blaustein R, Henderson L, Wei K, Nigrovic P. TNF-Stimulated Production of IL-15 by Fibroblast-Like Synoviocytes Mediates Human Resident Memory T Cells Development in Synovial Organoid Model [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/tnf-stimulated-production-of-il-15-by-fibroblast-like-synoviocytes-mediates-human-resident-memory-t-cells-development-in-synovial-organoid-model/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/tnf-stimulated-production-of-il-15-by-fibroblast-like-synoviocytes-mediates-human-resident-memory-t-cells-development-in-synovial-organoid-model/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology